GBS-NN/NN2
Sponsors
Minervax ApS
Conditions
Group B Streptococcal InfectionGroup B Streptococcal InfectionsGroup B Streptococcus InfectionPrevention of Group B streptoccoccus infection
Phase 1
Study to Assess a Booster Dose of GBS-NN/NN2 Vaccine
CompletedNCT05005247
Start: 2021-08-17End: 2022-08-05Updated: 2024-10-10
Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Participants
CompletedNCT05782179
Start: 2023-03-01End: 2024-05-23Updated: 2025-09-05
Phase 2
Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV
CompletedNCT04596878
Start: 2020-11-19End: 2023-05-11Updated: 2026-07-14
A Multicentre, Parallel-Group, Observer-Blind, Randomised, Placebo-Controlled, Pivotal Trial Investigating the Safety and Immunogenicity of Group B Streptococcus Vaccine (GBS-NN/NN2) in Pregnant Women and Infants Born to Pregnant Women Vaccinated During Pregnancy
Not yet recruitingCTIS2026-525385-21-00
Target: 138Updated: 2026-09-18